AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma
NCT05740891
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
BCMA CAR-T cells injection
Sponsor
Zhejiang University
Collaborators
[object Object]